Vergoeding 2016-2020 voor ATC-subgroep A10BJ : Glucagonachtig peptide-1-agonisten (glp-1-agonisten)

  • Raming voor de totale Zvw-populatie
  2016 2017 2018 2019 2020
A10BJ01 Exenatide (Bydureon ®) 1.130.000 1.006.100 879.410 727.920 567.690
A10BJ02 Liraglutide (Victoza ®) 12.055.400 12.161.200 13.666.100 13.766.500 11.448.500
A10BJ03 Lixisenatide (Lyxumia ®) 35.703 51.647 90.202 83.478 62.650
A10BJ05 Dulaglutide (Trulicity ®) 622.090 1.699.200 2.757.000 2.636.800 3.517.800
A10BJ06 Semaglutide (Ozempic ®) . . 380.020 9.253.700 23.441.800
Totaal 13.843.193 14.918.147 17.772.732 26.468.398 39.038.440